Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2521–2544 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Sleep Disorders
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1996 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Advanced Malignant Solid Neoplasm, Delirium, Hematopoietic and Lymphatic System Neoplasm, Insomnia
Interventions: Best Practice, Electronic Health Record Review, Interview, Questionnaire Administration, Suvorexant; Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stress Reaction, Sleep Disturbance, Craving, Obesity
Interventions: Ashwagandha Root Extract Capsule, Placebo Capsule; Dietary Supplement · Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Nightmare
Interventions: Nightmare Deconstruction and Reprocessing, NightWare; Behavioral · Device
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 22 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: BONGO NASAL EPAP; Device
Lead sponsor: InnoMed Healthscience Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 6,501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: San Francisco, California • Portland, Oregon • Pittsburgh, Pennsylvania

Conditions: Obstructive Sleep Apnea, Neurocognitive Disorders
Interventions: Brain Imaging, Cognitive testing, Blood Biomarkers; Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Insomnia, Alcohol; Harmful Use
Interventions: Cognitive Behavioral Therapy for Insomnia, Sleep Hygeine; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Cancer, Sleep Disturbance, Anxiety, Depression, Inflammation, Fatigue
Interventions: Wellness app intervention #1, Wellness app intervention #2; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Phoenix, Arizona • Winston-Salem, North Carolina • San Antonio, Texas

Conditions: Health Personnel, Stress, Anxiety, Insomnia, Hyperarousal, Corona Virus Infection, Covid19
Interventions: Cereset Research; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: Eplivanserin (SR46349); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: HIV, AIDS, Peripheral Neuropathy, Pain, Sleep
Interventions: Splinting application to the lower extremities, Splint liner application; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Narcolepsy Type 1 (NT1)
Interventions: E2086, E2086 Placebo, Active Comparator, Active Comparator Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 12
States / cities: Santa Ana, California • Miami, Florida • Macon, Georgia + 9 more

Conditions: Post-Concussion Symptoms, Insomnia, Pain, Chronic, Depressive Symptoms
Interventions: HIRREM-SOP or Cereset, Cereset 2x; Device
Lead sponsor: Brain State Technologies, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Bethesda, Maryland • Fort Bragg, North Carolina

Conditions: Sleep Apnea, Obstructive
Interventions: Coblation (radiofrequency-based device); Device
Lead sponsor: ArthroCare Corporation; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Traumatic Brain Injury, Neurobehavioral Manifestation, Sleep Disorder, Fatigue
Interventions: Not listed
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 25 Years to 40 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cholecystitis, Cholelithiasis, Obstructive Sleep Apnea
Interventions: acetaminophen, IV preparation; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Mild Cognitive Impairment
Interventions: Tiempo Juntos Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 55 Years and older
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Restless Leg Syndrome
Interventions: incobotulinumtoxinA, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: REM Sleep Behavior Disorder, Parkinson Disease
Interventions: Sodium Oxybate, Placebo; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Allergic Rhinitis, Asthma, Back Pain, Benign Prostatic Hypertrophy, Bursitis, Depression, Anxiety, Diabetes Mellitus, Esophageal Reflux, HIV Infections, Hyperlipidemia, Hypertension, Insomnia, Irritable Bowel Syndrome, Obesity, Osteoporosis (Senile), Shoulder Pain, Sinusitis, Symptomatic Menopause, Urinary Incontinence, Urinary Tract Infection, Vaginitis
Interventions: Health Information Prescription; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Sleep Apnea
Interventions: Atomoxetine, Oxybutynin, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 70 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia
Interventions: pCBT-I; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Sleep Apnea, Obstructive, Apnea, Sleep
Interventions: aerSleep II; Device
Lead sponsor: Sommetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 15
States / cities: Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 10 more

Search by objective public record fields.

Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Functional Assessment of Ashwagandaha Root Extract During Weight Loss

Nightmare Deconstruction and Reprocessing vs. NightWare Wristband

Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)

Direct Referral for Apnea Monitoring

Postoperative Neurocognitive Disorders

The Insomnia Treatment and Problems Study for Veterans

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Cereset Research In Healthcare Workers During COVID-19

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy

A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

Neurotechnology Following Traumatic Brain Injury

Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery

Characterization of Fatigue in Military Personnel With Traumatic Brain Injuries

Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA

A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

A Novel Pharmacological Therapy for Obstructive Sleep Apnea

Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)

Study Using Negative Pressure to Reduce Apnea